TotalMarketCap

Arrowhead Pharmaceuticals

ARWRNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$9.067 B

$64.19 -0.93%

Close of 5 Oct 2026

As of 5 Oct 2026, Arrowhead Pharmaceuticals (ARWR) has a market capitalization of $9.07B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$829.4M

#1633 by revenue

Earnings

-$1.63M

Loss-making

Shares outstanding

141,254,467

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →
  1. #34Axsome TherapeuticsAXSM$9.39B
  2. #35CytokineticsCYTK$9.12B
  3. #36Arrowhead PharmaceuticalsARWR$9.07B
  4. #37Protagonist TherapeuticsPTGX$9.06B
  5. #38Tg TherapeuticsTGTX$8.31B

What if Arrowhead Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $28.7T

$203,244.02

Per share 3,166× higher

Bitcoin $1.72T

$12,180.88

Per share 190× higher

Nvidia $5.64T

$39,915.16

Per share 622× higher

Or at a round number

$20.0B$50.0B$100.0B$200.0B

Where these numbers come from

Share counts and financials for Arrowhead Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 6 Oct 2026. Read the methodology.